We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$19.1B
AUM Growth
-$71.6M
Cap. Flow
+$375M
Cap. Flow %
1.97%
Top 10 Hldgs %
20.96%
Holding
1,713
New
9
Increased
554
Reduced
98
Closed
38

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$83.2M
2
DQ
Daqo New Energy
DQ
+$42.7M
3
DAR icon
Darling Ingredients
DAR
+$33M
4
TER icon
Teradyne
TER
+$25.8M
5
IQV icon
IQVIA
IQV
+$25.1M

Sector Composition

Rank Sector Weight
1 Technology 24.47%
2 Healthcare 17.68%
3 Consumer Discretionary 14.03%
4 Financials 13.08%
5 Industrials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPN icon
1201
Appian
APPN
$2.65B
$629K ﹤0.01%
6,800
NUVA
1202
DELISTED
NuVasive, Inc.
NUVA
$629K ﹤0.01%
10,516
HCM icon
1203
HUTCHMED
HCM
$2.11B
$626K ﹤0.01%
17,100
MD icon
1204
Pediatrix Medical
MD
$2.14B
$625K ﹤0.01%
22,000
+4,500
+26% +$137K
BOX icon
1205
Box
BOX
$4.66B
$624K ﹤0.01%
26,353
ANF icon
1206
Abercrombie & Fitch
ANF
$4.84B
$621K ﹤0.01%
16,500
ROCK icon
1207
Gibraltar Industries
ROCK
$1.45B
$621K ﹤0.01%
8,909
SLGN icon
1208
Silgan Holdings
SLGN
$4.46B
$621K ﹤0.01%
16,188
NKTR icon
1209
Nektar Therapeutics
NKTR
$2.57B
$620K ﹤0.01%
2,302
MGNI icon
1210
Magnite
MGNI
$3.53B
$616K ﹤0.01%
22,000
WWW icon
1211
Wolverine World Wide
WWW
$1.63B
$616K ﹤0.01%
20,632
CVBF icon
1212
CVB Financial
CVBF
$4.08B
$615K ﹤0.01%
30,211
+4,800
+19% +$94.8K
ASB icon
1213
Associated Banc-Corp
ASB
$6.07B
$614K ﹤0.01%
28,662
IOVA icon
1214
Iovance Biotherapeutics
IOVA
$2.95B
$614K ﹤0.01%
24,900
EGBN icon
1215
Eagle Bancorp
EGBN
$877M
$612K ﹤0.01%
10,651
+1,400
+15% +$78.4K
MSM icon
1216
MSC Industrial Direct
MSM
$6.77B
$612K ﹤0.01%
7,630
CCOI icon
1217
Cogent Communications
CCOI
$530M
$611K ﹤0.01%
8,630
COLB icon
1218
Columbia Banking Systems
COLB
$9.18B
$611K ﹤0.01%
16,088
MYGN icon
1219
Myriad Genetics
MYGN
$303M
$610K ﹤0.01%
18,888
XHR
1220
Xenia Hotels & Resorts
XHR
$1.76B
$610K ﹤0.01%
34,400
NUS icon
1221
Nu Skin
NUS
$236M
$608K ﹤0.01%
15,016
+3,700
+33% +$187K
BOKF icon
1222
BOK Financial
BOKF
$8.85B
$606K ﹤0.01%
6,772
ACMR icon
1223
ACM Research
ACMR
$5.65B
$605K ﹤0.01%
16,500
PBH icon
1224
Prestige Consumer Healthcare
PBH
$2.43B
$605K ﹤0.01%
10,781
GTN icon
1225
Gray Television
GTN
$520M
$604K ﹤0.01%
26,460
+5,300
+25% +$117K

Similar funds

Handelsbanken Fonder's Q3 2021 Portfolio in Review

As of Q3 2021, Handelsbanken Fonder held 1,713 positions worth $19.1B, down 0.37% from $19.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.7%. Handelsbanken Fonder opened 9 new positions and exited 38, leaving the 1,713-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q3 2021 buy was Volta Inc.: 1,671,677 shares worth $14.5M.
  • Handelsbanken Fonder added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $83.2M increase.
  • Handelsbanken Fonder's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.3M.
  • Handelsbanken Fonder fully exited Johnson Controls International in Q3 2021, selling an estimated $19.2M.
  • Handelsbanken Fonder's ten largest holdings make up 21% of its $19.1B portfolio in Q3 2021.
  • Handelsbanken Fonder opened 9 new positions and closed 38 in Q3 2021.
  • Handelsbanken Fonder's portfolio value fell 0.37% quarter-over-quarter to $19.1B.

Based on Handelsbanken Fonder's 13F filing for Q3 2021, filed 10 Nov 2021.